1. Home
  2. EXEL vs MOS Comparison

EXEL vs MOS Comparison

Compare EXEL & MOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EXEL
  • MOS
  • Stock Information
  • Founded
  • EXEL 1994
  • MOS 1987
  • Country
  • EXEL United States
  • MOS United States
  • Employees
  • EXEL N/A
  • MOS N/A
  • Industry
  • EXEL Biotechnology: Biological Products (No Diagnostic Substances)
  • MOS Agricultural Chemicals
  • Sector
  • EXEL Health Care
  • MOS Industrials
  • Exchange
  • EXEL Nasdaq
  • MOS Nasdaq
  • Market Cap
  • EXEL 9.8B
  • MOS 8.6B
  • IPO Year
  • EXEL 2000
  • MOS 2004
  • Fundamental
  • Price
  • EXEL $36.17
  • MOS $32.68
  • Analyst Decision
  • EXEL Buy
  • MOS Buy
  • Analyst Count
  • EXEL 18
  • MOS 12
  • Target Price
  • EXEL $37.59
  • MOS $31.67
  • AVG Volume (30 Days)
  • EXEL 2.2M
  • MOS 5.6M
  • Earning Date
  • EXEL 05-13-2025
  • MOS 05-06-2025
  • Dividend Yield
  • EXEL N/A
  • MOS 2.70%
  • EPS Growth
  • EXEL 170.77
  • MOS N/A
  • EPS
  • EXEL 1.76
  • MOS 1.15
  • Revenue
  • EXEL $2,168,701,000.00
  • MOS $11,064,300,000.00
  • Revenue This Year
  • EXEL $5.78
  • MOS $11.40
  • Revenue Next Year
  • EXEL $10.94
  • MOS $0.23
  • P/E Ratio
  • EXEL $20.64
  • MOS $28.27
  • Revenue Growth
  • EXEL 18.50
  • MOS N/A
  • 52 Week Low
  • EXEL $20.14
  • MOS $22.36
  • 52 Week High
  • EXEL $40.26
  • MOS $32.29
  • Technical
  • Relative Strength Index (RSI)
  • EXEL 43.89
  • MOS 79.52
  • Support Level
  • EXEL $34.90
  • MOS $29.45
  • Resistance Level
  • EXEL $40.26
  • MOS $30.90
  • Average True Range (ATR)
  • EXEL 1.21
  • MOS 0.97
  • MACD
  • EXEL -0.19
  • MOS 0.33
  • Stochastic Oscillator
  • EXEL 23.69
  • MOS 99.37

About EXEL Exelixis Inc.

Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.

About MOS Mosaic Company (The)

Mosaic is one of the largest phosphate and potash producers in the world. The company's assets include phosphate rock mines in Florida, Brazil, and Peru and potash mines in Saskatchewan, New Mexico, and Brazil. Mosaic also runs a large fertilizer distribution operation in Brazil through its Mosaic Fertilizantes business.

Share on Social Networks: